FLYRCADO Trademark

Trademark Overview

On Thursday, December 8, 2022, a trademark application was filed for FLYRCADO with the United States Patent and Trademark Office. The USPTO has given the FLYRCADO trademark a serial number of 97709172. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, June 12, 2025. This trademark is owned by GE Healthcare Limited. The FLYRCADO trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical agent for use in PET imaging
flyrcado

General Information

Serial Number97709172
Word MarkFLYRCADO
Filing DateThursday, December 8, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements

Goods and ServicesDiagnostic radiopharmaceutical agent for use in PET imaging
Pseudo MarkFLYR CADO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code005
First Use Anywhere DateWednesday, February 19, 2025
First Use In Commerce DateWednesday, February 19, 2025

Trademark Owner History

Party NameGE Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChalfont St Giles Buckinghamshire HP84SP
GB
Party NameGE Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorwalk, CT 06851

Trademark Events

Event DateEvent Description
Thursday, January 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 12, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Friday, September 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 16, 2024SOU EXTENSION 1 GRANTED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 4, 2024SOU EXTENSION 2 FILED
Wednesday, December 4, 2024SOU EXTENSION 2 GRANTED
Thursday, December 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 14, 2025USE AMENDMENT FILED
Friday, March 14, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, June 12, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 12, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 16, 2024SOU EXTENSION 1 FILED

Related Keywords

flyrcado imaging agent radiopharmaceutical diagnostic